In Hypertension (high blood pressure) Moxovas A Tablet relaxes the blood vessels so that blood can flow more easily around your body. This lowers your blood pressure and reduces your risk of having a stroke, a heart attack, or kidney problems in the future. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should take it regularly as prescribed for this medicine to be most effective, even if you feel better.
It is unsafe to consume alcohol with Moxovas A Tablet.
Moxovas A Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Moxovas A Tablet during breastfeeding is not available. Please consult your doctor.
Moxovas A Tablet may cause side effects which could affect your ability to drive. Moxovas A Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Moxovas A Tablet should be used with caution in patients with kidney disease. Dose adjustment of Moxovas A Tablet may be needed. Please consult your doctor.
Moxovas A Tablet should be used with caution in patients with liver disease. Dose adjustment of Moxovas A Tablet may be needed. Please consult your doctor. Moxovas A Tablet is started at a lower dose in patients with liver disease and further increased slowly with careful monitoring.
If you miss a dose of Moxovas A Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Rangsubbs || ₹14.5/tablet (25% cheaper)